Patents by Inventor Alfred Kim

Alfred Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240073946
    Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a wireless device may perform packet detection or energy detection on a primary channel using a first packet detector. The wireless device may perform packet detection or energy detection on a first non-primary channel using a second packet detector. The wireless device may transmit a packet on the first non-primary channel based on packet detection for the primary channel or packet detection for the first non-primary channel. Numerous other aspects are described.
    Type: Application
    Filed: August 30, 2022
    Publication date: February 29, 2024
    Inventors: Yanjun SUN, George CHERIAN, Alfred ASTERJADHI, Abhishek Pramod PATIL, Gaurang NAIK, Sai Yiu Duncan HO, Abdel Karim AJAMI, Youhan KIM
  • Patent number: 11029318
    Abstract: In some embodiments, the present invention provides methods for treating pregnant patients at risk of adverse pregnancy outcome, including, in some embodiments, by measuring one or more of a level of iC3b, intact C3, and total C3.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: June 8, 2021
    Assignee: Kypha, Inc.
    Inventors: Nicholas Staten, Alfred Kim, Paul Olson
  • Publication number: 20180275139
    Abstract: In some embodiments, the present invention provides methods for predicting flare in subjects with autoimmune disease (e.g., lupus erythematosus). In some embodiments, pending flares may be reduced in severity and/or prevented from clinical manifestation in their entirety using provided methods. In some embodiments, the present invention provides methods for preventing or reducing the severity of a flare including the steps of determining in a sample from a subject suffering from lupus erythematosus a complement activation potential, administering a treatment or implementing a change in treatment if the complement activation potential is about 25% or higher, wherein a complement activation potential of about 25% or higher indicates that the subject will experience a flare within 30 days.
    Type: Application
    Filed: August 26, 2016
    Publication date: September 27, 2018
    Inventors: Nick Staten, Alfred Kim, Paul Olson